Fractyl Health (GUTS)Director bought ~$23K
Ajay Royan, Director at Fractyl Health, bought ~$23K of Fractyl Health shares.
- ~$23K
- Approx. value · 18K sh @ $1.28
- 18K
- Holds after · shares reported
- Traded
- Mar 14, 2025
- Filed
- Mar 18, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 30, 2025Insider · 2 peopleInsiders: 2 sales (~$83K)
- Jan 31, 2025Insider · 2 peopleInsiders: 2 sales (~$206K)
- Mar 13, 2025Insider · 3 peopleInsiders: 3 purchases (~$40K)
- Mar 14, 2025 · this disclosureInsiderDirector purchased ~$23K of GUTS shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Fractyl Health
For Fractyl Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GUTS page.
Other recent filings by Ajay Royan, Director
The full history of Ajay Royan, Director is on the profile page.
How this filing works
Other disclosures at Fractyl Health
- SEC Form 4Sep 16, 2026
- SEC Form 4Jun 15, 2026
- SEC Form 4Jun 11, 2026
- SEC Form 4Jun 11, 2026
- SEC Form 4Jun 9, 2026
- SEC Form 4Dec 8, 2025
Everything OQRO holds on this company is on its GUTS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data